Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To examine the associations between postmortem Alzheimer disease (AD) neuropathology and autopsy-verified cardiovascular disease.
Methods: The authors examined 99 subjects (mean age at death = 87.6; SD = 8.7) from the Mount Sinai School of Medicine Department of Psychiatry Brain Bank who were devoid of cerebrovascular disease–associated lesions or of non–AD-related neuropathology. Density of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) as well as coronary artery and aortic atherosclerosis, left ventricular wall thickness, and heart weight were measured. Partial correlations were used to assess the associations of the four cardiovascular variables with NPs and NFTs in the hippocampus, entorhinal cortex, and multiple regions of the cerebral cortex after controlling for age at death, sex, dementia severity, body mass index, and ApoE genotype. These analyses were also repeated separately for ApoE4 carriers and noncarriers.
Results: The extent of coronary artery disease and to a lesser extent atherosclerosis were significantly associated with the density of cardinal neuropathologic lesions of AD in this autopsy sample (significant correlations between 0.22 and 0.29). These associations were more pronounced for the ApoE4 allele carriers (n = 42; significant correlations between 0.34 and 0.47).
Conclusions: The degree of coronary artery disease is independently associated with the cardinal neuropathological lesions of Alzheimer disease. These associations are primarily attributable to individuals with the ApoE4 allele.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
- Christine M Hulette, Duke University Medical Center, Department of Pathology Box 3712 Durham, NC 27710[email protected]
- Kathleen Welsh-Bohmer
Submitted July 13, 2006 - Reply from the Authors
- Michal Schnaider Beeri, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1230, New York, NY 10029[email protected]
- Michael Rapp, Jeremy M. Silverman, James Schmeidler, Hillel T. Grossman, John T. Fallon, Dushyant P. Purohit, Daniel P. Perl, Aamir Siddiqui, Gerson Lesser, Clive Rosendorff, Vahram Haroutunian
Submitted July 13, 2006
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive personsL. B. Hoffman, J. Schmeidler, G. T. Lesser et al.Neurology, February 18, 2009 -
Articles
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathologyM. S. Beeri, J. Schmeidler, J. M. Silverman et al.Neurology, September 02, 2008 -
Article
Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathologySarah E. Monsell, Charles Mock, Catherine M. Roe et al.Neurology, May 03, 2013 -
Articles
APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest oldDaniel J. Berlau, María M. Corrada, Elizabeth Head et al.Neurology, March 02, 2009